Stock PAR PARADIGM BIOPHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Paradigm Biopharmaceuticals Limited

Equities

PAR

AU000000PAR5

Market Closed - Australian S.E.
Other stock markets
 02:10:04 2024-05-21 am EDT 		5-day change 1st Jan Change
0.25 AUD -3.85% Intraday chart for Paradigm Biopharmaceuticals Limited -10.71% -41.18%
Apr. 19 Paradigm Biopharmaceuticals Submits Documents to FDA for Phase 3 Osteoarthritis Program MT
Feb. 28 Paradigm Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PARADIGM BIOPHARMACEUTICALS LIMITED Stock Paradigm Biopharmaceuticals Limited
 60.84M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 54.04B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.92B
LONZA GROUP AG Stock Lonza Group AG
 41.96B
CELLTRION, INC. Stock Celltrion, Inc.
 28.35B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.35B
  1. Stock Market
  2. Equities
  3. PAR Stock
  4. Charts Paradigm Biopharmaceuticals Limited
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW